Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Prospective Evaluation of Low-dose Irinotecan and Cyberknife Stereotactic Body Radiotherapy in the Treatment of Patients With Colorectal Cancer and Limited Liver Metastasis

Trial Profile

Prospective Evaluation of Low-dose Irinotecan and Cyberknife Stereotactic Body Radiotherapy in the Treatment of Patients With Colorectal Cancer and Limited Liver Metastasis

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 26 Feb 2018

At a glance

  • Drugs Irinotecan (Primary)
  • Indications Colorectal cancer; Liver metastases
  • Focus Adverse reactions
  • Sponsors Advocate Health Care
  • Most Recent Events

    • 21 Feb 2018 Status changed from recruiting to withdrawn prior to enrolment.
    • 18 Sep 2015 Protocol has been amended in treatment table in change in SBRT dose and duration.
    • 18 Sep 2015 Planned End Date changed from 1 Oct 2023 to 1 Oct 2025, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top